480994-24-9

Upstream product

• 480994-25-0 ethyl 2-[4-(1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)-3-methoxyphenyloxy]acetate 
• 55326-07-3 1,3,6-trimethyl-5-nitrouracil 
• 875802-07-6 {4-[(E)-2-(1,3-Dimethyl-5-nitro-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-yl)-vinyl]-3-methoxy-phenoxy}-acetic acid 
• 84969-24-4 2-methoxy-4-carboxymethoxybenzaldehyde 

Downstream Products

• 1029402-13-8 C₂₈H₃₀N₄O₅ 
• 480992-71-0 C₂₇H₂₉N₅O₅ 
• 480992-75-4 C₂₈H₃₁N₅O₆ 

Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonists

A new series of 9-deazaxanthine derivatives with various substituents at the heterocyclic system were synthesized and evaluated for their binding affinities for the four human recombinant adenosine receptors, A 1A3 subtypes. A number

Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor

Over two hundred 1-, 3-, 8-, and 9-substituted-9-deazaxanthines were prepared and evaluated for their binding affinity at the recombinant human adenosine receptors, in particular at the hA2B and hA2A subtypes. Several ligands endowed